Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Total Current Liabilities (2018 - 2025)

Historic Total Current Liabilities for Bio (TELA) over the last 8 years, with Q3 2025 value amounting to $17.0 million.

  • Bio's Total Current Liabilities rose 70.59% to $17.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.0 million, marking a year-over-year increase of 70.59%. This contributed to the annual value of $15.6 million for FY2024, which is 806.86% down from last year.
  • As of Q3 2025, Bio's Total Current Liabilities stood at $17.0 million, which was up 70.59% from $19.1 million recorded in Q2 2025.
  • Over the past 5 years, Bio's Total Current Liabilities peaked at $19.1 million during Q2 2025, and registered a low of $5.6 million during Q1 2021.
  • Over the past 5 years, Bio's median Total Current Liabilities value was $15.0 million (recorded in 2024), while the average stood at $13.7 million.
  • As far as peak fluctuations go, Bio's Total Current Liabilities surged by 11791.42% in 2022, and later tumbled by 806.86% in 2024.
  • Bio's Total Current Liabilities (Quarter) stood at $10.6 million in 2021, then increased by 17.29% to $12.4 million in 2022, then surged by 36.8% to $17.0 million in 2023, then dropped by 8.07% to $15.6 million in 2024, then increased by 8.84% to $17.0 million in 2025.
  • Its last three reported values are $17.0 million in Q3 2025, $19.1 million for Q2 2025, and $16.5 million during Q1 2025.